Psychotic Disorders Clinical Trial
Official title:
Fitforlife- a Study of Mentor Led Physical Exercise for Persons Affected by Psychosis
Persons affected by psychosis have a shorter life expectancy mainly due to metabolic
disorders. This is partly due to the drugs but also to a sedentary life style.
It is often a life long disorder with decreased overall function and thus need of life long
care, both informal and formal. It is also a highly stigmatising disorder.
We are aiming at adding peer mentor led regular physical exercise to the open care of
psychosis. it is well-known that physical exercise increase overall function, decrease
metabolic risk factors and increase cognition. By using educated peer mentors who will lead
the exercise sessions this will have an anti-stigmatising effect and improve self-confidence.
Purpose and aims The overall purpose is to integrate peer-mentor supervised regular physical
exercise in the open care of persons affected by psychosis. For specific research questions
see separate information.
Recruitment of units and mentors Psychiatric open care units who are responsible for care of
persons affected by psychosis will be contacted. First in Stockholm then in the rest of
Sweden.
Those who are interested will assign 1-2 local contact persons from the staff and recruit 4
potential peer mentors among their patients.
Peer mentor education The peer mentors will be educated to be able to lead physical exercise
sessions for other patients. Two units (8 mentors) will be educated together and the local
contact persons will also attend. The education consists of three half days and is lead by a
person educated in health pedagogics and physical exercise. It consists of theory and
practice about physical exercise sessions with focus on circular training. A lof of emphasis
will be put put on leadership and encouragement. The curriculum of the education is based on
the pilot study.
Recruitment of participants The local contact persons together with the health care staff at
the local units will recruit participants to the exercise sessions.
They will also perform the initial and 6 month follow up examinations. In order to do this
they will receive education and support from the research team. A carefully written
instruction is administered. This procedure is described in detail in the study protocol.
Exercise sessions Each included unit will have exercise sessions at the unit. Numbers/week
depends on the number of recruited participants. Schedule will be done by the local peer
mentors and the local contact person together. The sessions will be entirely led by the peer
mentors.
Before the sessions the local contact persons will register the participants when they
arrive. After the session the peer mentor will report to the local contact person how the
session went. These data will be transferred to the research team.
Support to the peer mentors For six months the educated peer mentors will have support from a
health pedagogical team. The support is both face-to-face and electronic.
Time period The study will record data for 6 months.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Terminated |
NCT03230097 -
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
|
Phase 2 | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Active, not recruiting |
NCT05726617 -
Avatar Intervention for the Treatment of Cannabis Use Disorder in Patients With Severe Mental Health Disorders
|
N/A | |
Not yet recruiting |
NCT03807388 -
ReMindCare App for Patients From First Episode of Psychosis Unit.
|
N/A | |
Recruiting |
NCT02874573 -
Tocilizumab in Schizophrenia
|
Phase 1 | |
Completed |
NCT02906553 -
The Role of Nitric Oxide in Cognition in Schizophrenia
|
N/A | |
Terminated |
NCT02584114 -
Brain Effects of Memory Training in Early Psychosis
|
N/A | |
Withdrawn |
NCT02213887 -
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
|
Phase 4 | |
Completed |
NCT01981356 -
Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis
|
Phase 0 | |
Terminated |
NCT02841956 -
Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement
|
N/A | |
Recruiting |
NCT02009969 -
Serial Comparisons of Abdominal and Neurological MRI Scans
|
N/A | |
Recruiting |
NCT02848469 -
Irish Omega-3 Study
|
Phase 2 | |
Completed |
NCT02648321 -
Motivational Intervention for Physical Activity in Psychosis
|
N/A | |
Enrolling by invitation |
NCT00762866 -
Psychiatric Genotype/Phenotype Project Repository
|
||
Completed |
NCT00484302 -
Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis
|
N/A | |
Completed |
NCT00455234 -
Rapid Tranquillization Trial: TREC-India II
|
Phase 3 | |
Completed |
NCT00844922 -
Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)
|
Phase 2 | |
Completed |
NCT00130923 -
Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder
|
Phase 4 | |
Completed |
NCT00226278 -
Safety Study of ORG 34517 for Major Depression With Psychotic Features
|
Phase 2 |